Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 106, Issue 5, Pages -
Publisher
Oxford University Press (OUP)
Online
2014-04-04
DOI
10.1093/jnci/dju048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
- (2015) Isaiah G. Schauer et al. NEOPLASIA
- TGF- Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
- (2013) T.-L. Yeung et al. CANCER RESEARCH
- Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer
- (2012) Suk-Joon Chang et al. ANNALS OF SURGICAL ONCOLOGY
- The urokinase plasminogen activator system in breast cancer invasion and metastasis
- (2012) Linlin Tang et al. BIOMEDICINE & PHARMACOTHERAPY
- Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review
- (2012) J Borley et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lysyl Oxidase Plays a Critical Role in Endothelial Cell Stimulation to Drive Tumor Angiogenesis
- (2012) A.-M. Baker et al. CANCER RESEARCH
- Microenvironmental Regulation of Epithelial-Mesenchymal Transitions in Cancer
- (2012) D. Gao et al. CANCER RESEARCH
- High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway
- (2012) Kosuke Yoshihara et al. CLINICAL CANCER RESEARCH
- Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma
- (2012) J.-P. Gillet et al. CLINICAL CANCER RESEARCH
- Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer
- (2012) Miranda P. Ween et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Scores to Predict Ovarian Cancer Outcomes: A Worthy Goal, but Not Ready for Prime Time
- (2012) E. M. Swisher et al. JNCI-Journal of the National Cancer Institute
- Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
- (2012) Stefan Bentink et al. PLoS One
- SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer
- (2012) Jie Chen et al. PLoS One
- A seven-gene prognostic model for platinum-treated ovarian carcinomas
- (2011) R Sabatier et al. BRITISH JOURNAL OF CANCER
- Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
- (2011) Manfred Schmitt et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Metastatic Outgrowth Encompasses COL-I, FN1, and POSTN Up-Regulation and Assembly to Fibrillar Networks Regulating Cell Adhesion, Migration, and Growth
- (2010) Johanna Soikkeli et al. AMERICAN JOURNAL OF PATHOLOGY
- Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biology
- (2010) Keith A. Baggerly et al. Annals of Applied Statistics
- Activation of NF- B Signaling by Inhibitor of NF- B Kinase Increases Aggressiveness of Ovarian Cancer
- (2010) L. Hernandez et al. CANCER RESEARCH
- TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy
- (2010) Jian-Liang Chou et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Transforming growth factor-beta signaling and tumor angiogenesis
- (2010) Evangelia Pardali Frontiers in Bioscience-Landmark
- Periostin promotes ovarian cancer angiogenesis and metastasis
- (2010) Min Zhu et al. GYNECOLOGIC ONCOLOGY
- Predicting the Outcome of Cytoreductive Surgery for Advanced Ovarian Cancer
- (2010) Okechukwu A. Ibeanu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Gene Expression Profile ofBRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
- (2010) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Tackling the widespread and critical impact of batch effects in high-throughput data
- (2010) Jeffrey T. Leek et al. NATURE REVIEWS GENETICS
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
- (2010) A K Mitra et al. ONCOGENE
- Gene Expression Profile for Predicting Survival in Advanced-Stage Serous Ovarian Cancer Across Two Independent Datasets
- (2010) Kosuke Yoshihara et al. PLoS One
- Why Most Gene Expression Signatures of Tumors Have Not Been Useful in the Clinic
- (2010) S. Koscielny Science Translational Medicine
- A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
- (2009) Samuel C. Mok et al. CANCER CELL
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
- (2009) Janine T. Erler et al. CANCER CELL
- Gene expression profiling and prediction of clinical outcome in ovarian cancer
- (2009) Renaud Sabatier et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A prognostic gene expression index in ovarian cancer-validation across different independent data sets
- (2009) Carsten Denkert et al. JOURNAL OF PATHOLOGY
- Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer
- (2009) Anne P. G Crijns et al. PLOS MEDICINE
- A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
- (2008) T. Bonome et al. CANCER RESEARCH
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- How Large a Training Set is Needed to Develop a Classifier for Microarray Data?
- (2008) K. K. Dobbin et al. CLINICAL CANCER RESEARCH
- Tumor Stroma as a Target in Cancer
- (2008) F. Ahmed et al. CURRENT CANCER DRUG TARGETS
- Run Batch Effects Potentially Compromise the Usefulness of Genomic Signatures for Ovarian Cancer
- (2008) Keith A. Baggerly et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now